Abstract:The recently discovered p53-dependent DNA damage tolerance (DDT) pathway relies on its biochemical activities in DNA-binding, oligomerization, as well as complex formation with the translesion synthesis (TLS) polymerase iota (POLι). These p53-POLι complexes slow down nascent DNA synthesis for safe, homology-directed bypass of DNA replication barriers. In this study, we demonstrate that the alternative p53-isoforms p53β, p53γ, Δ40p53α, Δ133p53α, and Δ160p53α differentially affect this p53-POLι-dependent DDT pathway originally described for canonical p53α. We show that the C-terminal isoforms p53β and p53γ, comprising a truncated oligomerization domain (OD), bind PCNA. Conversely, N-terminally truncated isoforms have a reduced capacity to engage in this interaction. Regardless of the specific loss of biochemical activities required for this DDT pathway, all alternative isoforms were impaired in promoting POLι recruitment to PCNA in the chromatin and in decelerating DNA replication under conditions of enforced replication stress after Mitomycin C (MMC) treatment. Consistent with this, all alternative p53-isoforms no longer stimulated recombination, i.e., bypass of endogenous replication barriers. Different from the other isoforms, Δ133p53α and Δ160p53α caused a severe DNA replication problem, namely fork stalling even in untreated cells. Co-expression of each alternative p53-isoform together with p53α exacerbated the DDT pathway defects, unveiling impaired POLι recruitment and replication deceleration already under unperturbed conditions. Such an inhibitory effect on p53α was particularly pronounced in cells co-expressing Δ133p53α or Δ160p53α. Notably, this effect became evident after the expression of the isoforms in tumor cells, as well as after the knockdown of endogenous isoforms in human hematopoietic stem and progenitor cells. In summary, mimicking the situation found to be associated with many cancer types and stem cells, i.e., co-expression of alternative p53-isoforms with p53α, carved out interference with p53α functions in the p53-POLι-dependent DDT pathway.

p12 isoform‐2 is a regulatory subunit of human DNA polymerase delta and is dysregulated in various cancers

Loss of the p12 subunit of DNA polymerase delta leads to a defect in HR and sensitization to PARP inhibitors

Response of Human DNA Polymerase Ι Promoter to N-methyl-N′-nitro-N-nitrosoguanidine

Proteolysis of the Human DNA Polymerase Delta Smallest Subunit P12 by Μ-Calpain in Calcium-Triggered Apoptotic HeLa Cells

Switching of the Substrate Specificity of Protein Tyrosine Phosphatase N12 by Cyclin‐dependent Kinase 2 Phosphorylation Orchestrating 2 Oncogenic Pathways

Characterization of human DNA polymerase κ promoter in response to benzo[a]pyrene diol epoxide.

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells

Inactivating Mutations in Exonuclease and Polymerase Domains in DNA Polymerase Delta Alter Sensitivities to Inhibitors of dNTP Synthesis

p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway

POLM Variant G312R Promotes Ovarian Tumorigenesis Through Genomic Instability and COL11A1-NF-κB Axis.

DNA polymerase kappa stabilized by PTBP2 interacts with MRE11 and promotes genomic instability in leukemia cells

Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer

The P66 and P12 Subunits of DNA Polymerase Δ Are Modified by Ubiquitin and Ubiquitin-Like Proteins

P53 Isoforms Can Regulate P53 Transcriptional Activity

p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners

Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication

An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2

Cloning, Expression And Characterization Of Human Tissue-Specific Dna Polymerase Lambda 2

Pold4 Subunit of Replicative Polymerase δ Promotes Fork Slowing at Broken Templates

Melanoma-Derived DNA Polymerase Theta Variants Exhibit Altered DNA Polymerase Activity